Masquerade Syndromes: Malignancies Mimicking Inflammation in the Eye
Masquerade Syndromes: Malignancies Mimicking Inflammation in the Eye
复制标题
假面舞会综合症:模仿眼部炎症的恶性肿瘤
DOI:
10.1097/00004397-200201000-00016
复制
发表时间:
2002
影响因子:
--
通讯作者:
J. O'Brien
中科院分区:
文献类型:
--
作者:
Tony Tsai;J. O'Brien
The term masquerade syndrome first appeared in the ophthalmic literature in 1967 to describe a conjunctival carcinoma that had presented as chronic conjunctivitis. Since then, the masquerade syndrome label has been applied to a group of disorders that mimic ocular inflammatory disease. Although some benign conditions can be considered masquerade syndromes, most often the term refers to malignant entities. Ocular oncology, the subspecialty that concerns itself with ocular and orbital malignancies, is by nature a field of uncommon disorders. A discussion of the masquerade syndromes, therefore, becomes a study in uncommon presentations of uncommon diseases. Nevertheless, the subject deserves wide attention because, in many cases, the diseases that masquerade are not only vision-threatening but potentially fatal. Significant morbidity and mortality can be averted by early recognition and diagnosis of the masquerade. This end point can be achieved only when an examiner is familiar with these uncommon presentations and maintains an appropriate index of suspicion. This brief review concentrates on six malignant conditions that can masquerade as ocular inflammation: sebaceous gland carcinoma, intraocular lymphoma, periocular lymphoma, retinoblastoma, ocular melanoma, and ocular metastases. The aim is to emphasize epidemiological and clinical features that should raise an examiner’s suspicion for a masquerade syndrome and then to highlight maneuvers that may assist in making the diagnosis. For brevity, discussions regarding therapeutic choices have been avoided. For these six and many of the rarer masquerade syndromes, the best initial step to therapeutic success is early definitive diagnosis.
影响因子:
13.7
作者:
Gonder,JR;Shields,JA;Albert,DM;Augsburger,JJ;Lavin,PT
通讯作者:
Lavin,PT
影响因子:
8.9
作者:
Buettner,H;Bolling,JP
通讯作者:
Bolling,JP
影响因子:
13.7
作者:
Yap,EY;Robertson,DM;Buettner,H
通讯作者:
Buettner,H